- Display 30 Products per page
Published: June 22, 2012 | Price: $2,500.00 – $5,000.00
The wound care market requires constant innovation and scientific research is ongoing to find ways of improving healing outcomes in all types of wounds.The wound care industry is an incredibly diverse and highly competitive arena that is ever-changing. Kalorama Information feels that the market will continue to expand over the long term due to an aging population, longer life expectancies, and an increasing number of sicker patients across all care settings. This Kalorama Information report, World Wound Care Markets, is the...Published: June 15, 2012 | Price: $1,995.00 – $3,990.00
Veterinary diagnostics have incorporated technologies and methods gained from human diagnostics and mainstream healthcare to develop a now full-fledged sister market that remains open to further innovation. Major diagnostic methods in mainstream healthcare – immunodiagnostics, molecular testing (including nucleic acid testing), hematology and clinical chemistry – now have standard applications in the veterinary care of companion (pets) and food animals (livestock and production animals). This report, The World Market for Veterinary Diagnostics, looks at these trends and details: Markets for Consumer Animal...Published: June 6, 2012 | Price: $995.00 – $1,990.00
Use of mobile devices in the healthcare field has taken off in a way not surprising given the fast pace of healthcare work. Innovative companies have been well ahead of this trend and launched applications that are seeing revenues. Kalorama Information has studied the market over the past two years and found a growing market with room for new entrants. This Kalorama Information report, The Worldwide Market for Mobile Medical Apps detailsthe smartphone and other mobile applications or “apps” that are...Published: June 5, 2012 | Price: $3,995.00 – $7,990.00
Vaccines are one of the most dynamic parts of the pharmaceutical business today but future growth will depend on a considerable amount of potential vaccines in the pipeline.This Kalorama Information report What's Next in Vaccines? examines and estimates the market for vaccines that have yet to be launched. What diseases may see a prophylactics vaccine option in the coming years? Which vaccines will have the most successful business model? Who are the major companies in this market, and possible new entrants? What can...Published: June 1, 2012 | Price: $495.00 – $990.00
In February and March of 2012, Kalorama Information conducted a survey of 2,000 adults to ask them whether or not they would take a genetic test. This report, Consumer Testing and the Future of DTC Genetic Testing provides those results and compiles surveys from public and private sources to provide the following insights: Have Consumers Used a Self-Test Product? Would They Take a Genetic Test? Are They Concerned About Their Healthcare? What Diseases Are They Most Concerned About?...Published: May 23, 2012 | Price: $2,500.00 – $5,000.00
The worldwide respiratory device market continues to grow despite economic downturns mainly due to the aging of the world population and increasing incidence of COPD. The market encompasses many different products to help treat and monitor respiratory conditions as well as many large and small manufacturers. Products included in the worldwide respiratory device market include: Inhalers Nebulizers Airway/Mask Equipment Sleep Apnea Equipment Oxygen therapy equipment and ventilators Medical Humidifiers Respiratory Measurement Devices The analysis presented in this report is based...Published: May 11, 2012 | Price: $3,995.00 – $7,990.00
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a target protein or nucleic acid in a way that is useful for treatment of disease. The process by which molecules are identified for their therapeutic value involves synthesis and analysis of many derivatives of the original leads. There are several steps in the drug discovery...Published: May 7, 2012 | Price: $3,995.00 – $7,990.00
Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription. Many pharmaceutical companies seeking more revenue and international exposure have found an opportunity in the development of over-the-counter (OTC) drugs. OTC drugs are sold to consumers by convenience and grocery stores. However, new technology has allowed a new range of outlets including online sales and catalog. Drugs included in OTC segments are pain relievers, cough and cold remedies, sleeping aids, antifungals, and...Published: May 2, 2012 | Price: $1,500.00 – $3,000.00
Medical device makers faced a productive but challenging year in 2011. They innovated existing lines, launched new devices and invested in R&D. But they also experienced funding cutbacks and new taxes and regulations. In this report, The Global Market for Medical Devices, 3rd. Edition, Kalorama Information analyzes the current device market in the United States, Europe, Asia and globally, profiles the key players and discusses trends important for market watchers to know. The medical device market is vast -- everything...Published: April 6, 2012 | Price: $3,995.00 – $7,990.00
This report, The Market for Home Care Products, 7th. Edition covers the market for products specially designed to assist with regular tasks of daily living. Growth in the ambulatory aids market continues to be driven by several key trends including the aging U.S. population, new product introductions and relatively generous government reimbursement programs, despite recent modifications. As part of its market analysis, this report includes the following information: Current U.S. Market Size Estimates and Forecasts to 2016 Market Forecast to...Published: March 22, 2012 | Price: $3,500.00 – $7,000.00
This Kalorama Information report – The World Anesthesia Drug Market - focuses on three primary segments of anesthesia: General Anesthesia Local Anesthesia Adjunctive Therapies in Anesthesia The report covers both currently marketed and late stage development anesthesia drugs. For each of these segments the report contains: Products on the Market Products in Development Market Size and Forecast Market Share of Key Players Issues and Trends Revenues for each segment were generated using dollar and unit sales for each product. Forecasted...Published: March 15, 2012 | Price: $3,995.00 – $7,990.00
The advancing age of the population makes long-term care an important consideration for health marketers. This report, The Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living covers the most important segments of the long term care industry, each of which provide medical care and/or assistance with the activities of daily living (ADLs) on an ongoing basis: Nursing care; Home care; Hospice care; Assisted living. Kalorama Information publishes its fourth edition of this detailed report on the...Published: March 13, 2012 | Price: $2,500.00 – $5,250.00
This report, EMR 2012 is a look at the market and trends impacting electronic medical record software and related services. Included in the report are statistics influencing the industry, demographics; life expectancy, and company strategies. Information is presented as a U.S. market, with a section on key international markets. A market summary includes a total market analysis. Also included is a competitive analysis of leading EMR system providers. As part of its research, the report includes: 2011 Market Estimates for...Published: March 1, 2012 | Price: $3,995.00 – $7,990.00
This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various categories of prescription dermatological drugs, describing the global market and identifying major market factors that may help to shape the market for treatments in the future. It is a time of change for this market sector, with OTC product launches, rising skin cancer incidence and acquisitions in the industry, and this report takes those updated details into account in...Published: March 1, 2012 | Price: $3,500.00 – $7,000.00
This report analyzes the current and potential world market for medical MRI and ultrasound systems. This report generally reviews the nature and direction of research, as well as future markets for two key areas of imaging technology: Ultrasound and MRI. the report includes the following as part of its market coverage: Current Market Size and Forecast for MRI Systems Installed Base of MRI Systems (Open, Closed, Low to Mid Field, High Field) Estimated Cost of MRI Systems...Published: March 1, 2012 | Price: $3,500.00 – $7,590.00
In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests currently on the market and in development, the report profiles key competitors and discusses trends that are important for understanding this much-discussed growth area of the diagnostic industry. The concept of 'Personalized Medicine', as seen by Kalorama clinical diagnostics industry analyst Shara Rosen, is currently somewhere between dream and road to reality....Published: February 1, 2012 | Price: $995.00 – $1,990.00
A desire to deliver better care and make healthcare workers more productive, as well as the incentives and mandates for EMR usage, has made handhelds ubiquitous in healthcare worldwide. Increasingly healthcare providers are using devices that can provide information and allow them to research, communicate and order services on a mobile basis. This Kalorama Information report - Handhelds in Healthcare- represents Kalorama's second edition of its review of the market for these type of devices. The report focuses on two...Published: February 1, 2012 | Price: $3,800.00 – $7,600.00
This Kalorama Information report – The World Market for Anti-Infectives - focuses on three key segments of treatment: Antifungals (Allylamines, Azoles, Polyene Macrolides, Other Antifungals) Antibacterials (Aminoglycosides, Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, Sulfonamides, Tetracyclines, Others) Antivirals (Nucleoside Analogs, Transcriptase Inhibitors, DNA Polymerase Inhibitors, Protease Inhibitors, Other Antivirals) The report covers both currently marketed and late stage development products. Revenues for each segment were generated using dollar and unit sales for each product. A novel approach in this report is that...Published: February 1, 2012 | Price: $2,500.00 – $5,000.00
Vaccines are among the top revenue earners in recent years, and in some cases have assisted major pharmaceutical companies to revenue growth. But this is not without some trade-offs. Vaccines involve a complex production process. Is vaccine-making profitable? How much is the industry spending? How much is handed off to other companies and how much is made by the branded manufacturers? How many doses are produced by the industry? These are the type of questions that Kalorama Information has taken...Published: January 1, 2012 | Price: $2,500.00 – $5,000.00
This report, The World Market for Gastrointestinal Devices, details the market for endoscopes and other devices used for treating gastrointestinal conditions. There are many factors behind the growth of this market. Cancer is one of leading reasons for surgery with more than 1 million new cases of colorectal cancer reported each year around the world. Obesity is another reason for growth. More and more people worldwide are turning to gastric bypass (bariatric surgery) and gastric banding to aide in their...Published: January 1, 2012 | Price: $1,995.00 – $4,995.00
This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies) represents the fourth time that Kalorama Information has taken a comprehensive look at oncology therapeutics. The report focuses on several segments for cancer treatment including: Chemotherapy, - Subcategories include Alkylating Agents, Antimetabolites, Cytotoxic Agents, Plant Derivatives - Brands such as Elotaxin, Taxotere, Gemzar, Alimta and Temodar, with Market Share for each Hormone Therapy: - Subcategories include Corticosteroids, Hormone...Published: January 1, 2012 | Price: $1,995.00 – $3,990.00
There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. Stem cells also have value as a research tool, as their in vitro study would allow scientists to learn more about the function of various organs and the development of particular diseases; stem cells may also eventually permit drug developers to test emerging therapies on diseased cells....Published: December 1, 2011 | Price: $150.00 – $300.00
Kalorama Information reports on a wide range of topics related to healthcare industry markets in the United States. This report, The Kalorama U.S.Pharmaceutical, Medical Device, Diagnostics Markets provides a broad look at the healthcare system and a summary of the market for the healthcare industry in the United States. The report discusses a range of topics impacting the industry: Healthcare Reform - What Impact Will Be Had on Each Healthcare Industry? How Will Physicians, Patients, Payors, and the Uninsured Be...Published: November 1, 2011 | Price: $150.00 – $300.00
Arthritis is one of the most common human ailments worldwide. Arthritis is a complex family of musculoskeletal disorders with many causes that are not fully understood. The most crippling of the arthritis family is rheumatoid arthritis, which is an autoimmune disease. Successful treatment of arthritis has resulted from a growing array of therapies available to physicians. While these pharmaceutical products are still used regularly, new disease-modifying therapies have produced the most impressive results in treating more severe types of arthritis....Published: November 1, 2011 | Price: $150.00 – $300.00
Radiography includes mammography, computed tomography, traditional x-ray and digital x-ray. These imaging procedures are affected by a number of factors: advances in technology, consumer expectations for healthcare, declining reimbursement and coverage of medical expenses by insurance companies and the aging of the population are among the factors driving these imaging markets. This report, Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems from Kalorama Information, details these factors and provides 2011 market size and forecast to 2015 for...Published: November 1, 2011 | Price: $150.00 – $300.00
DNA Microarrays are utilized heavily by research labs for a number of tasks such as gene profiling, RNA detection and SNP analysis. But as Kalorama Information's DNA Market Trends report indicates, the market for these systems is about to experience change. The report authored by Kalorama Information biotech analyst Justin Saeks, is the result of surveys carried out with microarray labs to determine the current state of the microarray market and attempt to predict the future direction of the technologies....Published: October 15, 2011 | Price: $150.00 – $300.00
China's rapid economic development and the numerous steps of reform undertaken by the Chinese central government since 1997 have had clear and observable effects upon China's total healthcare services market and its product markets for pharmaceuticals, medical devices, and in vitro diagnostics (IVD). This progress has been augmented by a Reform program in 2009, which includes increased funding to improve services. What are the workings of China's healthcare system? How much progress has been made towards the promised vision of...Published: October 15, 2011 | Price: $150.00 – $300.00
Several cell culture-derived biopharmaceutical drugs were launched in the US and European markets in 2010. Biopharmaceuticals (recombinant proteins, monoclonal antibody and nucleic acid-based products) represent the fastest growing sector in the pharmaceutical industry. Driving the extraordinary interest in biopharmaceuticals is the ability of these large proteins to target diseases in a very specific manner, thus maximizing efficacy while minimizing side effects. Growth in the development and production of biopharmaceuticals is the most significant driver of the cell culture market. Biological...Published: October 1, 2011 | Price: $150.00 – $300.00
The World Health Organization has identified a group of diseases that are the world's most pressing health problems. This represents an opportunity for test manufacturers, particularly in POC testing. Because of their ability to deliver fast results at the point of care, rapid testing is a focus area of healthcare providers and payors in infectious disease prevention. Kalorama Information has been reporting on the rapid test area for several years and has identified the segments with the fastest growth, and...Published: August 1, 2011 | Price: $150.00 – $300.00
Advanced patient monitoring systems that provide wireless or remote patient monitoring to share data outside the immediate patient care area continue to see sales growth. Features on these devices can range from basic remote tracking ability to “face-to-face” interaction between clinicians and patients, or even data sorting of the vast amount of data collected in order to put it into the context of a patient’s condition. Many systems now transfer data to an electronic medical record (EMR), and some come...